Table 2.
Bassline echocardiographic findings of the patients among the two cardiotoxicity and non-cardiotoxicity groups.
| Total population (n = 100) |
Non-cardiotoxicity (n = 59) |
Cardiotoxicity (n = 41) |
P value | |
|---|---|---|---|---|
| RVID, cm | 3.30 ± 3.06 | 3.56 ± 4 | 2.93 ± 0.28 | 0.37 |
| LVIDd, cm | 4.66 ± 0.62 | 4.78 ± 0.73 | 4.5 ± 0.42 | 0.03* |
| LVIDs, cm | 3.84 ± 5.08 | 4.5 ± 6.8 | 3.02 ± 0.54 | 0.23 |
| IVSD, cm | 0.92 ± 0.99 | 1.03 ± 1.3 | 0.79 ± 0.15 | 0.28 |
| Left atrium area, cm | 14.95 ± 4.37 | 15.56 ± 4.77 | 14.15 ± 3.71 | 0.17 |
| Left atrium dimeter, cm | 3.28 ± 0.58 | 3.41 ± 0.59 | 3.13 ± 0.56 | 0.04 |
| LA volume, cm2 | 37.59 ± 16.35 | 39.4 ± 19.51 | 35.07 ± 10.4 | 0.26 |
| EDV, mL | 87.19 ± 29.17 | 91.81 ± 36.45 | 81.28 ± 14.04 | 0.08 |
| ESV, mL | 41.87 ± 23.09 | 45.25 ± 28.78 | 37.69 ± 12.28 | 0.13 |
| TRG max, mmHg | 22.91 ± 8.15 | 24 ± 9.05 | 21.34 ± 6.46 | 0.14 |
| PAP, mmHg | 27.16 ± 8.21 | 28.7 ± 9.04 | 25.38 ± 6.86 | 0.09 |
| IVC, cm | 1.50 ± 0.28 | 1.47 ± 0.28 | 1.53 ± 0.29 | 0.32 |
| TAPSE | 21.33 ± 3.54 | 20.71 ± 3.81 | 22.24 ± 2.94 | 0.04* |
| RVSP | 26.95 ± 7.07 | 27 ± 6.82 | 26.88 ± 7.56 | 0.95 |
| SPAP | 26.72 ± 7.53 | 27.07 ± 8.19 | 26.19 ± 6.53 | 0.58 |
| First follow GLS | − 0.36 ± 1.87 | -0.49 ± 2.44 | -0.19 ± 0.02 | 0.44 |
Abbreviations: Right Ventricular Internal Dimension (RVID), Left Ventricular Internal Dimension in Diastole (LVIDd), Left Ventricular Internal Dimension in Systole (LVIDs), Interventricular Septal Thickness in Diastole (IVSD), Left Atrial Area, Left Atrial Diameter, Left Atrial Volume (LA volume), End-Diastolic Volume (EDV), End-Systolic Volume (ESV), Tricuspid Regurgitation Gradient Maximum (TRG max), Pulmonary Artery Pressure (PAP), Inferior Vena Cava Diameter (IVC), Tricuspid Annular Plane Systolic Excursion (TAPSE), Right Ventricular Systolic Pressure (RVSP), Systolic Pulmonary Artery Pressure (SPAP), Global Longitudinal Strain (First follow GLS).